drugset / Trial / NCT00081913

Stem Cell Study for Patients With Heart Disease

NCT00081913 ↗

Phase 1 Completed 24 enrolled Losordo, Douglas, M.D.
RandomizedDouble-blindTreatment

Summary

The purpose of this study is to determine if cell therapy with your own cells (autologous cells) delivered with a catheter to regions of the heart with poor blood flow will be safe and if it will relieve your chest pain and/or your ability to exercise.

Timeline

Start
2004-01
Primary completion
2006-03
Completion
2006-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous CD34 Positive Cells Cell therapy — —